Global Imatinib Mesylate Market Research Report 2016

November 2016 | 108 pages | ID: GB8FA195A24EN
QYResearch

Abstracts

Notes:

Production, means the output of Imatinib Mesylate

Revenue, means the sales value of Imatinib Mesylate

This report studies Imatinib Mesylate in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Sanofi SA (France)
• Wyeth (US)
• GlaxoSmithKline Plc (UK)
• Abbott Laboratories (USA)
• Pfizer Inc. (USA)
• Eli Lilly and Company (US)
• Merck & Co., Inc. (US)
• Warner Chilcott plc (Ireland)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Imatinib Mesylate in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Imatinib Mesylate in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Imatinib Mesylate Market Research Report 2016

1 IMATINIB MESYLATE MARKET OVERVIEW

1.1 Product Overview and Scope of Imatinib Mesylate
1.2 Imatinib Mesylate Segment by Type
  1.2.1 Global Production Market Share of Imatinib Mesylate by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Imatinib Mesylate Segment by Application
  1.3.1 Imatinib Mesylate Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Imatinib Mesylate Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Imatinib Mesylate (2011-2021)

2 GLOBAL IMATINIB MESYLATE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Imatinib Mesylate Production and Share by Manufacturers (2015 and 2016)
2.2 Global Imatinib Mesylate Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Imatinib Mesylate Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Imatinib Mesylate Manufacturing Base Distribution, Sales Area and Product Type
2.5 Imatinib Mesylate Market Competitive Situation and Trends
  2.5.1 Imatinib Mesylate Market Concentration Rate
  2.5.2 Imatinib Mesylate Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL IMATINIB MESYLATE PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Imatinib Mesylate Production and Market Share by Region (2011-2016)
3.2 Global Imatinib Mesylate Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL IMATINIB MESYLATE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Imatinib Mesylate Consumption by Regions (2011-2016)
4.2 North America Imatinib Mesylate Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Imatinib Mesylate Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Imatinib Mesylate Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Imatinib Mesylate Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Imatinib Mesylate Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Imatinib Mesylate Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL IMATINIB MESYLATE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Imatinib Mesylate Production and Market Share by Type (2011-2016)
5.2 Global Imatinib Mesylate Revenue and Market Share by Type (2011-2016)
5.3 Global Imatinib Mesylate Price by Type (2011-2016)
5.4 Global Imatinib Mesylate Production Growth by Type (2011-2016)

6 GLOBAL IMATINIB MESYLATE MARKET ANALYSIS BY APPLICATION

6.1 Global Imatinib Mesylate Consumption and Market Share by Application (2011-2016)
6.2 Global Imatinib Mesylate Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL IMATINIB MESYLATE MANUFACTURERS PROFILES/ANALYSIS

7.1 Sanofi SA (France)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Imatinib Mesylate Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Sanofi SA (France) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Wyeth (US)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Imatinib Mesylate Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Wyeth (US) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline Plc (UK)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Imatinib Mesylate Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 GlaxoSmithKline Plc (UK) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Abbott Laboratories (USA)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Imatinib Mesylate Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Abbott Laboratories (USA) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer Inc. (USA)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Imatinib Mesylate Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Inc. (USA) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Eli Lilly and Company (US)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Imatinib Mesylate Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Eli Lilly and Company (US) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Merck & Co., Inc. (US)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Imatinib Mesylate Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Merck & Co., Inc. (US) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Warner Chilcott plc (Ireland)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Imatinib Mesylate Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Warner Chilcott plc (Ireland) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview

8 IMATINIB MESYLATE MANUFACTURING COST ANALYSIS

8.1 Imatinib Mesylate Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Imatinib Mesylate

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Imatinib Mesylate Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Imatinib Mesylate Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IMATINIB MESYLATE MARKET FORECAST (2016-2021)

12.1 Global Imatinib Mesylate Production, Revenue Forecast (2016-2021)
12.2 Global Imatinib Mesylate Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Imatinib Mesylate Production Forecast by Type (2016-2021)
12.4 Global Imatinib Mesylate Consumption Forecast by Application (2016-2021)
12.5 Imatinib Mesylate Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Imatinib Mesylate
Figure Global Production Market Share of Imatinib Mesylate by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Imatinib Mesylate Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Imatinib Mesylate Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Imatinib Mesylate Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Imatinib Mesylate Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Imatinib Mesylate Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Imatinib Mesylate Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Imatinib Mesylate Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Imatinib Mesylate Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Imatinib Mesylate Production of Key Manufacturers (2015 and 2016)
Table Global Imatinib Mesylate Production Share by Manufacturers (2015 and 2016)
Figure 2015 Imatinib Mesylate Production Share by Manufacturers
Figure 2016 Imatinib Mesylate Production Share by Manufacturers
Table Global Imatinib Mesylate Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Imatinib Mesylate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Imatinib Mesylate Revenue Share by Manufacturers
Table 2016 Global Imatinib Mesylate Revenue Share by Manufacturers
Table Global Market Imatinib Mesylate Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Imatinib Mesylate Average Price of Key Manufacturers in 2015
Table Manufacturers Imatinib Mesylate Manufacturing Base Distribution and Sales Area
Table Manufacturers Imatinib Mesylate Product Type
Figure Imatinib Mesylate Market Share of Top 3 Manufacturers
Figure Imatinib Mesylate Market Share of Top 5 Manufacturers
Table Global Imatinib Mesylate Production by Regions (2011-2016)
Figure Global Imatinib Mesylate Production and Market Share by Regions (2011-2016)
Figure Global Imatinib Mesylate Production Market Share by Regions (2011-2016)
Figure 2015 Global Imatinib Mesylate Production Market Share by Regions
Table Global Imatinib Mesylate Revenue by Regions (2011-2016)
Table Global Imatinib Mesylate Revenue Market Share by Regions (2011-2016)
Table 2015 Global Imatinib Mesylate Revenue Market Share by Regions
Table Global Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Table China Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Table India Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Imatinib Mesylate Consumption Market by Regions (2011-2016)
Table Global Imatinib Mesylate Consumption Market Share by Regions (2011-2016)
Figure Global Imatinib Mesylate Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Imatinib Mesylate Consumption Market Share by Regions
Table North America Imatinib Mesylate Production, Consumption, Import & Export (2011-2016)
Table Europe Imatinib Mesylate Production, Consumption, Import & Export (2011-2016)
Table China Imatinib Mesylate Production, Consumption, Import & Export (2011-2016)
Table Japan Imatinib Mesylate Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Imatinib Mesylate Production, Consumption, Import & Export (2011-2016)
Table India Imatinib Mesylate Production, Consumption, Import & Export (2011-2016)
Table Global Imatinib Mesylate Production by Type (2011-2016)
Table Global Imatinib Mesylate Production Share by Type (2011-2016)
Figure Production Market Share of Imatinib Mesylate by Type (2011-2016)
Figure 2015 Production Market Share of Imatinib Mesylate by Type
Table Global Imatinib Mesylate Revenue by Type (2011-2016)
Table Global Imatinib Mesylate Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Imatinib Mesylate by Type (2011-2016)
Figure 2015 Revenue Market Share of Imatinib Mesylate by Type
Table Global Imatinib Mesylate Price by Type (2011-2016)
Figure Global Imatinib Mesylate Production Growth by Type (2011-2016)
Table Global Imatinib Mesylate Consumption by Application (2011-2016)
Table Global Imatinib Mesylate Consumption Market Share by Application (2011-2016)
Figure Global Imatinib Mesylate Consumption Market Share by Application in 2015
Table Global Imatinib Mesylate Consumption Growth Rate by Application (2011-2016)
Figure Global Imatinib Mesylate Consumption Growth Rate by Application (2011-2016)
Table Sanofi SA (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi SA (France) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi SA (France) Imatinib Mesylate Market Share (2011-2016)
Table Wyeth (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Wyeth (US) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure Wyeth (US) Imatinib Mesylate Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Imatinib Mesylate Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories (USA) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Imatinib Mesylate Market Share (2011-2016)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. (USA) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Imatinib Mesylate Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company (US) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (US) Imatinib Mesylate Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. (US) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. (US) Imatinib Mesylate Market Share (2011-2016)
Table Warner Chilcott plc (Ireland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Warner Chilcott plc (Ireland) Imatinib Mesylate Production, Revenue, Price and Gross Margin (2011-2016)
Figure Warner Chilcott plc (Ireland) Imatinib Mesylate Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Imatinib Mesylate
Figure Manufacturing Process Analysis of Imatinib Mesylate
Figure Imatinib Mesylate Industrial Chain Analysis
Table Raw Materials Sources of Imatinib Mesylate Major Manufacturers in 2015
Table Major Buyers of Imatinib Mesylate
Table Distributors/Traders List
Figure Global Imatinib Mesylate Production and Growth Rate Forecast (2016-2021)
Figure Global Imatinib Mesylate Revenue and Growth Rate Forecast (2016-2021)
Table Global Imatinib Mesylate Production Forecast by Regions (2016-2021)
Table Global Imatinib Mesylate Consumption Forecast by Regions (2016-2021)
Table Global Imatinib Mesylate Production Forecast by Type (2016-2021)
Table Global Imatinib Mesylate Consumption Forecast by Application (2016-2021)